Transversal Categories

R&D into orphan drugs is growing alongside the number of approved treatments, providing treatments for rare diseases that

Orphan drugs’ financial success raises questions

https://pharmaphorum.com/market-access-2/orphan-drugs-financial-success-raises-questions/

News/ News/ UK & Europe

Judge shuts down Servier’s argument that NHS should have stopped prescribing its drugs

Jonah Comstock ACE inhibitors, drug prices, generics, perindopril, Servier 0 Comment

A London high court judge ruled this week that the damages paid to the NHS for an anticompetitive

Judge shuts down Servier’s argument that NHS should have stopped prescribing its drugs

https://pharmaphorum.com/news/judge-shuts-down-serviers-argument-that-nhs-should-have-stopped-prescribing-its-drugs/

News/ US

Endo, Florida reach $65M opioid settlement

Jonah Comstock Endo, Florida, opioid crisis 0 Comment

Endo Pharmaceuticals and Endo Health Solutions, makers of Percocet, Opana, and Percodan, have settled with the State of

Endo, Florida reach $65M opioid settlement

https://pharmaphorum.com/news/endo-florida-reach-65m-opioid-settlement/

Supreme Court columns with American flag and US Capitol

News/ US

US Supreme Court blocks Biden’s broad vaccine mandate in 6-3 decision

Jonah Comstock COVID-19 vaccine, Joe Biden, US Supreme Court, vaccine mandate 0 Comment

The US Supreme Court handed down two decisions today relating to COVID-19 vaccine mandates, issuing a stay to

US Supreme Court blocks Biden’s broad vaccine mandate in 6-3 decision

https://pharmaphorum.com/news/us-supreme-court-blocks-bidens-broad-vaccine-mandate-in-6-3-decision/

Articles/ Oncology/ R&D/ R&D/ Sales and Marketing/ US/ Views & Analysis/ Views & Analysis/ Views & Analysis/ Views and analysis

A history of Johnson & Johnson

Claire A history of..., Alex Gorsky, J&J, Janssen, Johnson & Johnson, Paul Janssen 0 Comment

Set up by three brothers back in 1886, Johnson & Johnson continues to keep evolving

A history of Johnson & Johnson

https://pharmaphorum.com/views-analysis-sales-marketing/a-history-of-johnson-johnson/

Patients/ Rare diseases/ Views & Analysis/ Views and analysis

Ring 20: Could the rare disease get left behind by next-generation gene sequencing?

mike.hammerton@pharmaphorum.com Exploring Rare Diseases, patient insights, Rare diseases, Ring 20 Research and Support, Ring Chromosome 20 syndrome 0 Comment

Ring Chromosome 20 Syndrome, or (R)20, is an ultra-rare form of epilepsy with a devastating impact – yet

Ring 20: Could the rare disease get left behind by next-generation gene sequencing?

https://pharmaphorum.com/views-analysis-patients/ring-20-could-the-rare-disease-get-left-behind-by-next-generation-gene-sequencing/

News/ News/ R&D/ R&D

Pfizer’s Revatio flunks paediatric hypertension study

Phil Taylor paediatric clinical trials, paediatrics, Pfizer, pulmonary hypertension 0 Comment

An attempt by Pfizer to extend the uses of its pulmonary artery hypertension (PAH) drug Revatio into a

Pfizer’s Revatio flunks paediatric hypertension study

https://pharmaphorum.com/news/pfizers-revatio-flunks-paediatric-hypertension-study/

R&D/ R&D/ Views & Analysis/ Views and analysis

R&D Roundup: Pharma gets in on the biotech boom

George Underwood Alexion, Alnylam, Biotech, Cell Mogrify, Novartis, R&D, Roche, Spark Therapeutics, UK 0 Comment

Some good news for the UK industry in turbulent times is always welcome, and several announcement this month

R&D Roundup: Pharma gets in on the biotech boom

https://pharmaphorum.com/r-d/views-analysis-r-d/rd-roundup-pharma-gets-in-on-the-biotech-boom/

News/ News/ R&D/ R&D

Merck & Co pens $340m pain drug deal with KCL and Wellcome

Richard Staines Merck & Co, pain, R&D 0 Comment

Merck & Co has announced a deal with King’s College London (KCL) and Wellcome to investigate a new

Merck & Co pens $340m pain drug deal with KCL and Wellcome

https://pharmaphorum.com/news/merck-co-pens-340m-pain-drug-deal-with-kcl-and-wellcome/

1 2 3 4 ›»

CONTINUE TO SITE >

Close in 10 seconds

Pharmaphorum.com

Trending

Transversal Categories

Login